An Ohio judge has ordered a hospital to treat a ventilated patient with Ivermectin. India used Ivermectin to stem its delta variant outbreak. The science shows that ivermectin is a cheap, safe, effective therapeutic for COVID-19. Yet, the FDA warns against its use to fight COVID-19. The wife of a hospitalized COVID-19 patient sued after the hospital refused to administer properly prescribed Ivermectin. The court granted relief to the wife, ordering the hospital to administer Ivermectin to her ventilated husband.
Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.
Yet, the FDA warns against Ivermectin as a COVID-19 therapeutic.
The FDA has not reviewed data to support use of ivermectin in COVID-19 patients to treat or to prevent COVID-19; however, some initial research is underway. Taking a drug for an unapproved use can be very dangerous. This is true of ivermectin, too.
They haven’t gotten around to reviewing the data. (Maybe too busy fending off White House demands for booster approval? Don’t worry. Trust the “science”. Trust the “experts”.)